Short promo video for the Sept. 21 2021 immersion workshop on finding and searching data through the AD Knowledge Portal. Leveraging the expertise of the AD Knowledge Portal community, the workshop introduces infrastructure, metadata, and downstream analyses. Learn more and view the full recording of the Technical Workshop.
The Emory-Sage-SGC TREAT-AD center is taking an open science approach to promoting the study of under-studied AD genes and proteins by providing packages of information and reagents specific to targets to encourage their research as therapeutic AD targets by the research community. Join Drs. Riham Ayoubi and Alison Axtman to discuss strategies and methods for the selection of adequate cell lines for antibody characterization and the assembly and annotation of the AD Informer Set to enable research of targets identified by the AD consortia. Read about the initiative and sign up for the TREAT-AD webinar.
The Model Organism Development and Evaluation for Late-onset Alzheimer’s Disease (MODEL-AD) consortium discussed their goals, including the development of new models based on recent human genetics, the alignment of AD pathophysiology in mouse models and human studies, the staging of disease progression, and preclinical testing based on translatable biomarkers.
Dr. Gregory Carter is an Associate Professor at The Jackson Laboratory, Bar Harbor, ME. He combines genetic, genomic, imaging, and other data resources to understand the causes and progression of Alzheimer’s disease.